EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ateroprotective effects of Plinia cauliflora in. New Zealand rabbits: beyond the lipid-lowering effect

Ana Paula Cestari, Francielly Mourão Gasparotto, Cândida Aparecida Leite Kassuya, Tauany Milan Ribeiro Lacerda, Guilherme Donadel, Catia Sari Moura, Daniela Boleta Ceranto, Ezilda Jacomassi, Odair Alberton, Salviano Belletini Tramontini, Luana Ale Bertoncello, Arquimedes Gasparotto Junior und 1 weitere

Frontiers in Pharmacology · 12.01.2024 · 15

DOI: 10.3389/fphar.2024.1244632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.01.2024. Verfasst von Ana Paula Cestari und 12 weiteren Autor:innen. Beteiligte Einrichtung: Master's Degree in Medicinal Plants and Herbal Medicines in Basic Healthcare, Paranaense University, Umuarama, Brazil. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Apoio Ao Desenvolvimento Do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Plinia cauliflora [Mart.] Kausel (Myrtaceae), popularly known as “jabuticaba,” is a fruit species native to Brazil. Despite extensive widespread usage, its antiatherosclerotic properties' impact remains unknown. Thus, the present study aimed to investigate the cardioprotective effects of a preparation obtained from the fruit peels of P. cauliflora (EEPC).

Methods

Male New Zealand rabbits received a 1% cholesterol-supplemented diet for 60 days. On the thirtieth day, the animals were divided into five experimental groups and received, once a day, by the oral route, the EEPC (10, 30, and 100 mg/kg), simvastatin (2.5 mg/kg), or vehicle for 30 days. At the end of the experimental period, peripheral blood and arterial branch samples were collected. The levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), malondialdehyde (MDA), nitrotyrosine (NT), nitrite, interleukin 1 beta (IL-1b), interleukin 6 (IL-6), soluble inter-cellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) levels were measured. Moreover, the catalase and superoxide dismutase levels were measured on the arterial samples. Histopathological analysis and arterial morphometry were also performed. Results and discussion: The oral administration of ESEG significantly lowered the levels of lipids in rabbits that were fed a CRD diet. This treatment also adjusted the protective system against oxidation in the arteries by decreasing the oxidation of lipids and proteins. Additionally, the levels of IL-1b, IL-6, sICAM-1, and sVCAM-1 in the bloodstream decreased significantly, and this was accompanied by a reduction of atherosclerotic lesions in all branches of the arteries. The findings suggest that EEPC may be a possible option for additional management of atherosclerosis.

Schlagwörter

Stichwörter der Autor:innen

anti-inflammatoryantioxidantatherosclerosiscardioprotectivejabuticaba

Autor:innen und Institutionen

  • Master's Degree in Medicinal Plants and Herbal Medicines in Basic Healthcare, Paranaense University, Umuarama, Brazil.
  • Laboratory of Cardiovascular Pharmacology (LaFaC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Brazil.

Förderung

  • Fundação de Apoio Ao Desenvolvimento Do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Cestari, A. P., Gasparotto, F. M., Kassuya, C. A. L., Lacerda, T. M. R., Donadel, G., Moura, C. S., Ceranto, D. B., Jacomassi, E., Alberton, O., Tramontini, S. B., Bertoncello, L. A., Gasparotto Junior, A., & Lourenço, E. L. B. (2024). Ateroprotective effects of Plinia cauliflora in. New Zealand rabbits: beyond the lipid-lowering effect. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1244632

Vancouver

Cestari AP, Gasparotto FM, Kassuya CAL, Lacerda TMR, Donadel G, Moura CS, et al. Ateroprotective effects of Plinia cauliflora in. New Zealand rabbits: beyond the lipid-lowering effect. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1244632

BibTeX
@article{Cestari2024,
  author = {Cestari, Ana Paula and Gasparotto, Francielly Mourão and Kassuya, Cândida Aparecida Leite and Lacerda, Tauany Milan Ribeiro and Donadel, Guilherme and Moura, Catia Sari and Ceranto, Daniela Boleta and Jacomassi, Ezilda and Alberton, Odair and Tramontini, Salviano Belletini and Bertoncello, Luana Ale and Gasparotto Junior, Arquimedes and Lourenço, Emerson Luiz Botelho},
  title = {Ateroprotective effects of Plinia cauliflora in. New Zealand rabbits: beyond the lipid-lowering effect},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1244632}
}
Kostenlos starten →